Cargando…
A Candidate Prognostic Biomarker Complement Factor I Promotes Malignant Progression in Glioma
Objectives: Glioma is the most common and aggressive type of primary central nervous system (CNS) tumor in adults and is associated with substantial mortality rates. The aim of our study was to evaluate the prognostic significance and function of the complement factor I (CFI) in glioma. Materials an...
Autores principales: | Cai, Xiaomin, Qiu, Wenjin, Qian, Mengshu, Feng, Shuang, Peng, Chenghao, Zhang, Jiale, Wang, Yi, Wang, Yuhai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889977/ https://www.ncbi.nlm.nih.gov/pubmed/33614625 http://dx.doi.org/10.3389/fcell.2020.615970 |
Ejemplares similares
-
Targeting the Complement Pathway in Malignant Glioma Microenvironments
por: Zhu, Hongtao, et al.
Publicado: (2021) -
Differential and Prognostic Significance of HOXB7 in Gliomas
por: Zhou, Xingang, et al.
Publicado: (2021) -
Exosomal miR-2276-5p in Plasma Is a Potential Diagnostic and Prognostic Biomarker in Glioma
por: Sun, Jingxian, et al.
Publicado: (2021) -
HSPA6 is Correlated With the Malignant Progression and Immune Microenvironment of Gliomas
por: Zhou, Xiang, et al.
Publicado: (2022) -
A Prognostic Ferroptosis-Related lncRNAs Signature Associated With Immune Landscape and Radiotherapy Response in Glioma
por: Zheng, Jianglin, et al.
Publicado: (2021)